Sunrest LifescienceNSE:SUNREST 41 EV-to-FCF is 26.47 as of Jul. 12, 2026, which is 46% above its 10-year median of 18.19. GuruFocus rates NSE:SUNREST with a GF Score™ of 41/100. The stock has 5 warning signs investors should review. Among 403 Healthcare Providers & Services companies, Sunrest Lifescience ranks worse than 65.26% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sunrest Lifescience's Enterprise Value is ₹410.1 Mil.
Sunrest Lifescience's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹15.5 Mil. Therefore, Sunrest Lifescience's EV-to-FCF for today is 26.47.
The historical rank and industry rank for Sunrest Lifescience's EV-to-FCF or its related term are showing as below:
NSE:SUNREST'
s EV-to-FCF Range Over the Past 10 Years
Min: -5.31 Med: 18.19 Max: 30.19
Current: 26.47
During the past 7 years, the highest EV-to-FCF of Sunrest Lifescience was 30.19. The lowest was -5.31. And the median was 18.19.
NSE:SUNREST's EV-to-FCF is ranked worse than 65.26% of 403
companies
in the Healthcare Providers & Services industry
Industry Median: 18.07
vs NSE:SUNREST: 26.47
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sunrest Lifescience's PE Ratio (TTM) for today is calculated as:
Sunrest Lifescience's share price for today is ₹35.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sunrest Lifescience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.790.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Sunrest Lifescience EV-to-FCF Related Terms
Sunrest Lifescience EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Sunrest Lifescience's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Sunrest Lifescience's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunrest Lifescience EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sunrest Lifescience's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Sunrest Lifescience's EV-to-FCF falls into.
Sunrest Lifescience's current Enterprise Value is ₹410.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sunrest Lifescience's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹15.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunrest Lifescience (NSE:SUNREST) has a EV-to-FCF of 26.47 as of Jul. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sunrest Lifescience and its competitors. This is 46% above median its historical median of 18.19. According to the industry distribution chart, Sunrest Lifescience ranks #263 out of 403 companies in the Healthcare Providers & Services industry, placing it in the top 65.3%.
Is Sunrest Lifescience's EV-to-FCF too high?
Sunrest Lifescience's current EV-to-FCF of 26.47 is 46% above median its 10-year median of 18.19. The Healthcare Providers & Services industry median EV-to-FCF is 18.07. Sunrest Lifescience's value of 26.47 is 46.5% above this industry median. Based on the distribution chart, Sunrest Lifescience ranks #263 out of 403 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Sunrest Lifescience has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's EV-to-FCF compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sunrest Lifescience ranks #263 out of 403 companies for EV-to-FCF. This places Sunrest Lifescience in the lower half of its industry. The industry median EV-to-FCF is 18.07. Sunrest Lifescience's value of 26.47 is 46.5% above this benchmark. While the company's 10-year median is 18.19 vs. the industry median of 18.07, Sunrest Lifescience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.07, based on 403 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunrest Lifescience's current EV-to-FCF of 26.47 is 46.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sunrest Lifescience and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunrest Lifescience's current EV-to-FCF is 26.47, which is 46% above median its own 10-year median of 18.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current EV-to-FCF of 26.47. The current EV-to-FCF is 26.47, which is 46% above median its 10-year median of 18.19 and 46.5% above the Healthcare Providers & Services industry median of 18.07. Sunrest Lifescience's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current EV-to-FCF is 26.47 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
41GF Score
Get the complete analysis for NSE:SUNREST
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SUNREST has been successfully added to your 
